GRI Bio Inc reports results for the quarter ended September 30 - Earnings Summary

GRI Bio

15/11/2024 14:06

* GRI Bio Inc  GRI.OQ  reported a quarterly adjusted loss
of 67
cents​​ per share for the quarter ended September 30.  The lone
analyst forecast for the quarter was for a loss of 73 cents per
share. 
    * Reported revenue was zero​; analysts expected zero. 
    * GRI Bio Inc's reported EPS for the quarter was a loss
of 67
cents​.
    * The company reported a quarterly loss of $2.12 million.
    * GRI Bio Inc shares had risen by 165.9% this quarter and
lost 97.3% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for GRI Bio Inc is
12.00 
This summary was machine generated from LSEG data November 15 at
02:06 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.73          -0.67          Beat